StatPearls, LLC

  • Biopsy
  • Biopsy, Large-Core Needle
  • Divorce
  • Hemangiosarcoma
  • Sarcoma

Sarcoma

Soft tissue sarcomas (STS) are a group of neoplasms that can affect individuals at the extremes of age and can originate from any location throughout the human body. These neoplasms can span a range of clinical presentations, from aggressive metastatic angiosarcomas to benign lipomas. These need to be evaluated using imaging studies and biopsy (core needle biopsy or incisional biopsy). The real challenge in diagnosing these conditions is that there are several non-neoplastic conditions that mimic STS. Soft tissue sarcomas are separated categorically as trunk and extremity from retroperitoneum. This activity illustrates the evaluation and management of sarcomas and explains the role of the interprofessional team in managing patients with this condition.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 2 creditsAAPA Category 1 Credit™Up to 2 creditsAMA PRA Category 1 Credit™Up to 2 creditsNursingUp to 2 creditsPharmacyUp to 2 credits

MOC types

ABS — Accredited CMEUp to 2 pointsABOS — Accredited CMEUp to 2 pointsABPATH — Lifelong LearningUp to 2 pointsABPMR — Accredited CMEUp to 2 pointsABTS — Accredited CMEUp to 2 pointsABIM — Medical KnowledgeUp to 2 pointsABS — Self-AssessmentUp to 2 pointsABP — Lifelong Learning and Self-AssessmentUp to 2 pointsABPMR — Self-AssessmentUp to 2 pointsABTS — Self-AssessmentUp to 2 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 9 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 2 credits
  • MOC · Up to 2 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left